“Emerging biopharma companies (EBP) represent a significant and growing portion of the global clinical outsourcing market.”

In this interview with President, R&D Solutions at IQVIA Richard Staub, you will learn about:

• The launch of IQVIA Biotech to serve biotech and biopharma companies
• Specific needs of biopharma companies that are currently not addressed in the marketplace
• Services biopharma companies increasingly seek to outsource

Contact us to learn how IQVIA Biotech helps biopharma customers reach drug development and commercialization milestones.